Grant number: IH190100021 | Funding period: 2021 - 2026
Active
Gerald L Murray, Erica L Plummer, Kaveesha Bodiyabadu, Lenka A Vodstrcil, Jose L Huaman, Jennifer A Danielewski, Teck Phui Chua, Dorothy A Machalek, Suzanne Garland, Michelle Doyle, Emma L Sweeney, David M Whiley, Catriona S Bradshaw
2023-02-01
BACKGROUND: While single nucleotide polymorphisms (SNPs) in Mycoplasma genitalium parC contribute to fluoroquinolone treatment fai..
Emma L Sweeney, Catriona S Bradshaw, Gerald L Murray, David M Whiley
2022-08-24
Mycoplasma genitalium is an emerging global health threat, due to an alarming rise in antimicrobial resistance. Although individua..
Gerald L Murray, Kaveesha Bodiyabadu, Lenka A Vodstrcil, Dorothy A Machalek, Jennifer Danielewski, Erica L Plummer, Suzanne M Garland, David M Whiley, Emma L Sweeney, Catriona S Bradshaw
2022-04-27
Prevalence, trends, and treatment outcome estimates were generated for parC variants in macrolide-resistant Mycoplasma genitalium...
Teck-Phui Chua, Jennifer Danielewski, Kaveesha Bodiyabadu, Catriona S Bradshaw, Dorothy A Machalek, Suzanne M Garland, Erica L Plummer, Lenka A Vodstrcil, Gerald L Murray
2022-04-14
Doxycycline targets the 16S rRNA and is widely used for the treatment of sexually transmitted infections. While it is not highly e..
Jacob A Tickner, Catriona S Bradshaw, Gerald L Murray, David M Whiley, Emma L Sweeney
2022-03-30
BACKGROUND: Mycoplasma genitalium infection is a sexually transmitted infection that has rapidly become resistant to mainstay trea..
Lenka A Vodstrcil, Erica L Plummer, Michelle Doyle, Gerald L Murray, Kaveesha Bodiyabadu, Jorgen S Jensen, David Whiley, Emma Sweeney, Deborah A Williamson, Eric PF Chow, Christopher K Fairley, Catriona S Bradshaw
2022-01-04
BACKGROUND: Mycoplasma genitalium (MG) infection is challenging to cure because of rising antimicrobial resistance and limited tre..